United States Cellular (UZE) Rule 144: 22,977 Shares Proposed Sale via Morgan Stanley

Rhea-AI Filing Summary

United States Cellular Corporation (UZE) - Rule 144 notice discloses a proposed sale of 22,977 common shares through Morgan Stanley Smith Barney on the NYSE with an aggregate market value of $1,736,116.85. The filing itemizes the acquisition origin and timing for the shares being offered: performance shares and restricted stock granted in March and April 2025 totaling 22,977 shares. It also reports a recent sale by the same person of 26,459 shares on 08/12/2025 for gross proceeds of $2,005,332.74. The filer certifies they are not aware of undisclosed material adverse information about the issuer.

Positive

• Transparent disclosure of the proposed sale amount (22,977 shares) and aggregate market value ($1,736,116.85)
• Source of shares clearly identified as performance shares and restricted stock with acquisition dates in March and April 2025
• Prior sale disclosed (26,459 shares for $2,005,332.74), aiding investor visibility into insider transactions

Negative

• Insider selling activity increases share supply and could be perceived negatively by some market participants
• No operational or financial context is provided here to offset interpretation of the insider sales

Insights

Securities Analyst

TL;DR: Routine Rule 144 notice showing insider liquidity from recent grants and a prior sale; no new operational facts disclosed.

The notice documents a planned disposition of 22,977 common shares derived from recent equity awards (performance shares and restricted stock granted in March and April 2025). The transaction is to occur via Morgan Stanley Smith Barney on the NYSE and is accompanied by a recent sale of 26,459 shares producing approximately $2.0 million in gross proceeds. There is no operational or financial performance information in the filing and the signer affirms absence of undisclosed material adverse information. For investors, this is a disclosure about insider selling and share supply, not a statement about company fundamentals.

Corporate Governance Expert

TL;DR: Governance filing meets Rule 144 disclosure requirements; shows insiders monetizing recent equity grants.

The form clearly links the securities to specific award types and grant dates (restricted stock and performance shares from March-April 2025), which supports transparency around insider compensation and subsequent sales. The prior sale on 08/12/2025 and the proposed sale reported here should be monitored for pattern analysis, but the filing itself contains no allegation of misconduct or governance breach. It fulfills the attestation required under Rule 144 regarding material non-public information.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	22977	1736116.85	86000000	08/14/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/04/2025	Peformance Shares	Issuer			5729	04/04/2025	Not Applicable
Common	03/04/2025	Restricted Stock	Issuer			4349	03/04/2025	Not Applicable
Common	04/04/2025	Restricted Stock	Issuer			6295	04/04/2025	Not Applicable
Common	04/03/2025	Restricted Stock	Issuer			6604	04/03/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Kevin Lowell 500 West Madison Street Suite 810 Chicago IL 60661	Common	08/12/2025	26459	2005332.74

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does this Form 144 for UZE disclose?

The notice discloses a proposed sale of 22,977 common shares on the NYSE via Morgan Stanley Smith Barney with an aggregate market value of $1,736,116.85.

What types of shares are being sold under this filing?

The shares originate from performance shares and restricted stock granted in March and April 2025, totaling 22,977 shares.

Did the filer recently sell other shares?

Yes. The filing reports a prior sale by the same person of 26,459 common shares on 08/12/2025 generating gross proceeds of $2,005,332.74.

Where will the proposed sale take place?

The proposed sale is to be executed through Morgan Stanley Smith Barney LLC on the NYSE.

Does the filer assert there is undisclosed material information?

By signing the form the person represents they do not know any material adverse information about the issuer that has not been publicly disclosed.